Bioabsorbable Scaffolds – Current and Future Players

Coronary artery disease (CAD) and peripheral artery disease (PAD) are global public health and socioeconomic issues that affect millions of lives each year. Bioabsorbable scaffolds (BAS), which provide transient support to the vessel, are viable alternatives to permanent drug-eluting stents (DES) and bare metal stents (BMS) implants. In the report, BAS are defined as fully-bioabsorbable devices that are used in stenting procedures that completely disappear from the target vessel overtime. Stents such as BioMatrix Flex by Biosensors International and Synergy by Boston Scientific Corporation are not included in the report because they are metallic DES with bioabsorbable polymer coatings. Absorption of the bioabsorbable polymer coating still leaves behind a permanent BMS inside the vessel. The report provides up-to-date information and in-depth analysis on the key players that shape the global bioabsorbable scaffolds market. The report includes an analysis of company profiles, industry trends, and corporate strategy. This report is built using data and information sourced from secondary sources, primary research interviews with leading cardiovascular experts, and in-house analysis conducted by GlobalData’s team of industry experts. *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.


Investigation of current and future market competition for advanced wound dressings.

Competitive Assessment including product profiles.

Coverage of key market players, which includes company profiles, business descriptions, financial overviews, portfolio assessments, and SWOT analyses.

Strategic Assessment of the market through market impact analysis, future market scenario, and company analysis.

Reasons to buy

Gain a high level view of the trends shaping and driving the bioabsorbable scaffolds market.

Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

Drive revenues, formulate effective sales and marketing strategies, and gain in-depth understanding of the competitive landscape.

Create an effective counter-strategy to gain a competitive advantage against those currently in the market.

Table of Contents

1Table of Contents

1.1List of Tables



2.2Related Reports

3Competitive Assessment


3.2Absorb BVS – Abbott Vascular


3.3Remedy – Kyoto Medical Planning


3.4DESolve – Elixir Medical Corperation


3.5Pure – Arterial Remodeling Technologies


4Pipeline Products


4.2Coronary Artery Disease – Pipeline Products


4.2.2Polymer-Based Bioabsorbable Scaffolds

4.2.3Metallic Bioabsorbable Scaffolds


4.3Peripheral Artery Disease – Peripheral Bioabsorbable Scaffold Product Pipeline



5Current and Future Players


5.2Trends in Corporate Strategy

5.3Company Profiles

5.3.1Abbott Vascular

5.3.2Kyoto Medical Planning Co., Ltd.

5.3.3Arterial Remodeling Technologies

5.3.4Elixir Medical Corporation


5.3.6Reva Medical

5.3.7OrbusNeich Medical

5.3.8Amaranth Medical


5.3.10Lepu Medical Technology

5.3.11HuaAn Biotechnology Co., Ltd.

5.3.12Lifetech Scientific (Shenzhen) Co., LTD. (Lifetech Shenzhen)


5.3.14S3V Vascular Technologies

5.3.15Tepha Inc.

5.3.16Zorion Medical

5.3.17Xenogenics Corporation

5.3.18Meril Life Sciences

5.3.19Boston Scientific Corporation

5.3.20Icon Interventional Systems




6.3Report Methodology



6.3.3Primary Research –Key Opinion Leader Interviews

6.3.4Primary Research Interviews – Physician and Industry Participants

6.3.5Physician Survey

6.3.6Expert Panel Validation

6.3.7Secondary Research

6.4Forecasting Methodology

6.5Physicians and Specialists Included in This Study

6.6About the Authors


6.6.2James Coutcher, Global Head of Healthcare

6.7About GlobalData

6.8Contact Us


List of Tables

Table 1: Marketed BAS Products

Table 2: Absorb BVS Product Profile

Table 3: Absorb BVS Clinical Trials

Table 4: Absorb BVS SWOT Analysis, 2015

Table 5: Remedy Product Profile

Table 6: Remedy SWOT Analysis, 2015

Table 7: DESolve Product Profile

Table 8: DESolve Clinical Trials

Table 9: DESolve SWOT Analysis, 2015

Table 10: Pure Product Profile

Table 11: Pure SWOT Analysis, 2015

Table 12: Coronary BAS Product Pipeline, 2015

Table 13: Igaki-Tamai Stent SWOT Analysis, 2015

Table 14: Fantom Scaffold SWOT Analysis, 2015

Table 15: ART18Z Scaffold SWOT Analysis, 2015

Table 16: Fortitude Scaffold SWOT Analysis, 2015

Table 17: ArterioSorb Scaffold SWOT Analysis, 2015

Table 18: ArterioSorb Scaffold SWOT Analysis, 2015

Table 19: Xinsorb Scaffold SWOT Analysis, 2015

Table 20: Ideal BioStent SWOT Analysis, 2015

Table 21: DREAMS Scaffold SWOT Analysis, 2015

Table 22: Peripheral BAS Product Pipeline, 2015

Table 23: Magic Explorer Scaffold SWOT Analysis, 2015

Table 24: ESPRIT BVS Stent SWOT Analysis, 2015

Table 25: Abbott Vascular Company Profile

Table 26: Marketed BAS Products by Abbott Vascular

Table 27: Pipeline BAS Products by Abbott Vascular

Table 28: Abbott Vascular SWOT Analysis, 2015

Table 29: Kyoto Medical Planning Company Profile

Table 30: Marketed BAS Products by Kyoto Medical Planning

Table 31: Pipeline BAS Products by Kyoto Medical Planning

Table 32: Kyoto Medical Planning SWOT Analysis, 2015

Table 33: ART Company Profile

Table 34: Marketed BAS Products by ART

Table 35: ART’s BAS Pipeline Products

Table 36: ART SWOT Analysis, 2015

Table 37: Elixir Medical Corporation Company Profile

Table 38: Marketed BAS Products by Elixir Medical

Table 39: Elixir Medical Corporation SWOT Analysis, 2015

Table 40: Cardionovum Company Profile

Table 41: Cardionovum’s BAS Pipeline Products

Table 42: Cardionovum SWOT Analysis, 2015

Table 43: REVA Medical’s BAS Pipeline Products

Table 44: REVA Medical SWOT Analysis, 2015

Table 45: OrbusNeich Medical Company Profile

Table 46: OrbusNeich Medical’s BAS Pipeline Products

Table 47: OrbusNeich Medical SWOT Analysis, 2015

Table 48: Amaranth Medical Company Profile

Table 49: Amaranth Medical’s BAS Pipeline Products

Table 50: Amaranth Medical SWOT Analysis, 2014

Table 51: Biotronik Company Profile

Table 52: Biotronik’s BAS Pipeline Products

Table 53: Biotronik SWOT Analysis, 2015

Table 54: Lepu Medical Technology Company Profile

Table 55: Lepu Medical Technology’s BAS Pipeline Products

Table 56: Lepu Medical Technology SWOT Analysis, 2015

Table 57: HuaAn Biotechnology Co., Ltd. Company Profile

Table 58: HuaAn Biomedical Co., Ltd.’s BAS Pipeline Products

Table 59: HuaAn Biomedical Co., Ltd. SWOT Analysis, 2015

Table 60: Lifetech Scientific Co., LTD Company Profile

Table 61: Lifetech Scientific’s BAS Pipeline Products

Table 62: Lifetech Scientific SWOT Analysis, 2015

Table 63: Arterius Company Profile

Table 64: Arterius BAS Pipeline Products

Table 65: Arterius SWOT Analysis, 2015

Table 66: S3V Vascular Technologies Company Profile

Table 67: S3V Vascular Technologies’ BAS Pipeline Product

Table 68: S3V Vascular Technologies SWOT Analysis, 2015

Table 69: Tepha Inc. Company Profile

Table 70: Tepha Inc.’s BAS Pipeline Product

Table 71: Tepha Inc. SWOT Analysis, 2015

Table 72: Zorion Medical Company Profile

Table 73: Zorion Medical’s BAS Pipeline Product

Table 74: Zorion Medical SWOT Analysis, 2015

Table 75: Xenogenics Corporation Company Profile

Table 76: Xenogenics Corporation’s BAS Pipeline Product

Table 77: Xenogenics Corporation SWOT Analysis, 2015

Table 78: Meril Life Sciences Company Profile

Table 79: Meril Life Science’s BAS Pipeline Product

Table 80: Meril Life Sciences SWOT Analysis, 2015

Table 81: Boston Scientific Corporation Company Profile

Table 82: Boston Scientific Corporation SWOT Analysis, 2015

Table 83: Icon Interventional Systems Company Profile

Table 84: Primary Research Interviews Completed

Table 85: Physicians Surveyed, By Country

List of Figures



Discounts available for multiple purchases.
+44 20 7947 2745

Join our mailing list

Saved reports